Prof. Gao obtained his Ph.D. at Sun Yat-sen University Cancer Center, P. R. China in 2012. He subsequently completed his postdoctoral research fellowship program at University of Rochester University Medical Center (URMC, USA). He has rich clinical experience in minimally invasive and interventional treatment of hepatocellular carcinoma with portal hypertension (especially TIPS procedure), radiofrequency (microwave) ablation, radioactive seed implantation of solid tumor and biliary stent implantation for malignant obstructive jaundice. As the sponsor and executive chairman, he had hosted 8 consecutive "China Southern TIPS Forum". As the first author and/or corresponding author, Prof. Gao has published over 60 papers in prestigious, international peer-reviewed journals, such as Radiology and European Radiology. He has been supported by the National Natural Science Foundation of China (NSFC) and National Natural Science Foundation of Guangdong, etc.

 

Prof. Gao has received the First prize of scientific and technological progress of Guangdong Province (2020); Second prize of scientific and technological progress award of China Anti-Cancer Association (2019); "The cutting edge of intervention in China" (2019, CCI); "National Famous doctors in China: Young Pioneer" (2017); Research Fellowship of URMC (University of Rochester Medical Center, USA); "The second prize of national outstanding young interventional physician research award (2015)"; "The first prize of the excellent paper in the 16th Annual Conference of Chinese Interventional Brachyseed Society (CIBS)"; etc.

1.Microwave ablation for solid tumors.

2.Study on the advantage of treatment for hepatic carcinoma with hypersplenism by TACE combined with splenic microwave ablation.

3.Biliary stents placement

6/20/2003 Bachelor of Medical ImagingSun Yat-sen UniversityGuangzhou, China

6/22/2009 Master of Medical ImagingSun Yat-sen University Guangzhou, China

6/26/2012 M.D. of Oncology,Sun Yat-sen University Guangzhou, China

1.Wenliang Zhu#, Zhenkang Qiu#, Huzheng Yan, Zhihui Zhong, Weiwei Jiang, Fujun Zhang,* and Fei Gao* .Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts. Diagn Interv Radiol. 2022 28(6): 616–620.
2.Huzheng Yan#, Zhenkang Qiu#, Zhanwang Xiang, Kai Feng, Mingsheng Huang*, Fei Gao*. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging. 2022; 22: 13.  
3.Zhenkang Qiu#, Wenliang Zhu#, Huzheng Yan, Guobao Wang, Mengxuan Zuo, Han Qi, Guisong Wang, Weiwei Jiang, Jingbing Xue, Fujun Zhang*, Fei Gao*. Single-Centre Retrospective Study Using Propensity Score Matching Comparing Left Versus Right Internal Jugular Vein Access for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation. Cardiovasc Intervent Radiol. 2022; 45(5): 563–569.
4.Zhenkang Qiu#, Guobao Wang#, Guang Yang, Guisong Wang, Weiwei Jiang, Zixiong Chen, Wenliang Zhu, Huanqing Guo, Fujun Zhang*, Fei Gao*. Transcriptome sequencing-based personalized analysis of hepatocellular carcinoma patients with portal vein tumor thrombus. J Gastrointest Oncol. 2021 Apr; 12(2): 795–805. 
5.Zixiong Chen#, Xiaobo Fu#, Zhenkang Qiu, Maoyuan Mu, Weiwei Jiang, Guisong Wang, Zhihui Zhong, Han Qi*, Fei Gao*. CT-guided 125I Brachytherapy for Hepatocellular Carcinoma in High-risk Locations after Transarterial Chemoembolization Combined with Microwave Ablation: A Propensity Score-matched Study Radiol Oncol. 2023 Mar; 57(1): 127–139. 
6.Zhenkang Qiu#, Guobao Wang#, Huzheng Yan, Han Qi, Mengxuan Zuo, Guisong Wang, Weiwei Jiang, Zixiong Chen, Jingbing Xue, Ligong Lu, Fujun Zhang*, Fei Gao*. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol. 2022; 32(10): 6777–6787. 
7.Huzheng Yan#, Guobao Wang#, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang*, Fei Gao*. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Transl Oncol. 2020 Dec; 13(12): 100864. 
8.Huzheng Yan#, Ma Luo#, Lifei Wang, Zhenkang Qiu, Zhiqiang Mo, Zhanwang Xiang, Yanling Zhang, Guanyu Chen, Zhihui Zhong, Xiuchen Wang, Fei Gao*, Fujun Zhang*. Clinical efficacy and prognostic factors of CT-guided 125I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes. Cancer Imaging. 2020; 20:25. 
9.Zhenkang Qiu, Gui Song Wang, Fei Gao. Whole-course management of interventional treatment in liver cancer patients with portal hypertension J Interv Med. 2019 May; 2(2): 52–54.Correction in: J Interv Med. 2020 Dec; 3(4): 216.
10.Xiaobo Fu#, Weiwei Jiang#, Maoyuan Mu, Guobao Wang, Han Qi, Zixiong Chen, Mengxuan Zuo*, Fei Gao*. Effect of percutaneous stenting strategy of unresectable malignant hilar biliary obstruction by three‐dimensional reconstruction volumetry. Cancer Med. 2023 Apr; 12(8): 9506–9516.
11.Ye Sheng#, Xiaobo Fu#, Guobao Wang, Maoyuan Mu, Weiwei Jiang, Zixiong Chen, Han Qi*, Fei Gao*. Safety and efficacy of self-expandable metallic stent combined with 125I brachytherapy for the treatment of malignant obstructive jaundice. Cancer Imaging. 2023; 23: 33. 
12.Wang G, Zhang F, Yang B, Xue J, Peng S, Zhong Z, Zhang T, Lu M, Gao F*.   Feasibility and Clinical Value of CT-guided (125)I Brachytherapy for Bilateral Lung Recurrences from Colorectal Carcinoma. Radiology. 2016 Mar;278(3):897-905. 
13.Mo Z#, Zhang T#, Zhang Y, Xiang Z, Yan H, Zhong Z, Gao F*, Zhang  F*.   Feasibility  and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure. Eur Radiol. 2018 Mar;28(3):1194-1203. 
14. Yan H#, Xiang Z#, Zhong Z#, Mo Z, Zhang T, Chen G, Zhang F*, Gao F*. CT-guided 125I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region. Transl Oncol. 2017 Feb;10(1):90-98. 
15. Yan H#, Mo Z#, Xiang Z, Rong D, Zhang Y, Chen G, Zhong Z, Zhang F*, Gao F*. CT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma. J Cancer. 2017 Jul 5;8(11):2104-2113. 
16. Xiang Z#, Mo Z#, Li G#, Gilani S, Zhong Z, Zhang T, Zhang F*, Gao F*. 125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments. Oncotarget. 2016 Apr 5;7(14):18384-93. 
17. Gao F, Li C, Gu Y, Huang J, Wu P. CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients. Eur J Radiol 2013; 82(2):e70-75. 
18.  Zhang T#, Lu M#, Peng S, Zhang W, Yang G, Liu Z, Singh S, Yang Y, Zhang F*, Gao F*. CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy. J Cancer Res Clin Oncol 2014;140(8):1383-1390. 
19.  Yang G#, Peng S#, Zhang Y, Liu Z, Lu M, Zhang T, Gao F*, Zhang F*. Cell-based assay system to estimate the effect of 125I seeds on cancer cells: effect of osteopontin. Recent Pat Anticancer Drug Discov 2014; 9(2):258-263.
20.  Yang G#, Zhang S#, Gao F#, Liu Z, Lu M, Peng S, Zhang T, Zhang F. 
Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1. Biochim Biophys Acta. 2014; 1839(9):837-848.   
21.  Gao F, Gu YK, Huang JH, Zhao M, Wu PH*. Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma, Acad Radiol; 2012; 19(8):1035-1040. 
22.  Gao F, Gu YK, Fan WJ, Zhang L, Huang JH*, Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol; 2011; 17(26):3145-3150.   
23.  Gao F, Gu YK, Shen JX, Li CL, Jiang XY, Huang JH*, Experimental study of  destruction to porcine spleen in vivo by microwave ablation. World J Gastroenterol; 2011; 17(45):5014-5020. 
24. Gao F#, Zhong R#, Li GH, Zhang WD*. Computed tomography and magnetic  resonance imaging findings of inflammatory myofibroblastic tumors of the head  and neck. Acta Radiol, 2014; 55(4):434-440.   
25.  Gao F, He N, Wu PH*. The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancer. Chin J   2014, 33(11):569-73.
26.  Gao F#, Wang GB#, Xiang ZW#, Yang B, Xue JB, Mo ZQ, Zhong ZH, Zhang T, Zhang FJ *, Fan WJ *. A preoperative mathematic model for computed tomographic guided microwave ablation treatment of hepatic dome tumors. Oncotarget. 2016 May 3;7(18):25949-25959. 
27.  Liu Z#, Gao F#, Yang G, Singh S, Lu M, Zhang T, Zhong  Z, Zhang F, Tang R. Combination of radiofrequency ablation with transarterial  chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis. Tumour Biol, 2014; 35(8):7407-7413.  
28.  Jingxian Shen, Fei Gao*, Jing Zhao, Yunxian Mo, Peihong Wu. Small hepatocellular carcinoma keeping hypodense during dual phase helical CT scan and correlative pathology, J Biomed Graph Comput, 2013; 3(4):1-7. 
29.  Yongxin Chen, Fei Gao*, Lin Chen, Sheng Peng, Yingjie Huang, Yao Wang. Effectiveness and Safety of CT-Guided 125I Brachytherapy for Lung Metastasis from Hepatocellular Carcinoma. Open Journal of Radiology, 2013; 3:159-164. 
30. Zhanwang Xiang#, Lifei Wang#, Huzheng Yan, Zhihui Zhong, Wangkai Liu, Zhiqiang Mo, Fei Gao*, Fujun Zhang*. 125I seed brachytherapy versus external beam radiation therapy for the palliation of painful bone metastases of lung cancer after one cycle of chemotherapy progression. Oncotarget and Therapy, 2018,11:5183-5193.

Updated by International Office, Sun Yat-sen University Cancer Center